investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Pinar Ozden Eser

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Pinar Ozden Eser

Harvard University

Cambridge, United States

Related projects

Denise A. Galloway

Interactions of HPV Oncogenes With the p53 Pathway

Trachea, bronchus and lung

Robert Gillies

Radiomics of Non-Small Cell Lung Cancer (NSCLC)

Trachea, bronchus and lung

Pathology

Susan Bates

Translational Studies of the Histone Deacetylase Inhibitor Romidepsin

Trachea, bronchus and lung

Giovanna Tosato

A Role for KSHV in the Pathogenesis of Malignancies

Trachea, bronchus and lung

Pathology Hematology and hematologic malignancies

Gregory J Hannon

Cold Spring Harbor Laboratory Cancer Research Center

Trachea, bronchus and lung

Shioko Kimura

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

Trachea, bronchus and lung

Pathology

Carlo M Croce

MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment

Trachea, bronchus and lung

Simon D Spivack

Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker

Trachea, bronchus and lung

Guanghua Xiao

Integrative Analysis to Identify Therapeutic Targets for Lung Cancer

Trachea, bronchus and lung

Pathology